PsiQuantum and AMD are expanding strategic partnership to co-design the computing infrastructure required to operate utility-scale, fault-tolerant quantum computers and the hybrid applications that combine quantum, high-performance, and AI computing.
The collaboration builds on the companies’ existing work around AMD Versal FPGA technology, — selected by PsiQuantum for the development of its fault-tolerant quantum computing platform — and expands it into a broader relationship spanning AMD Instinct GPUs, AMD EPYC CPUs, and the AMD ROCm software stack, combined with PsiQuantum’s silicon photonics platform and its fully integrated platform.
As quantum systems scale toward practical use, PsiQuantum and AMD expect the integration of classical high-performance, AI, and photonic quantum computing technology to form the world’s most powerful hybrid computing fabric.
Also, AMD plans to make an equity investment into PsiQuantum.
Victor Peng, CEO of PsiQuantum, said quantum computing will enable solving problems in healthcare, materials, energy, finance, and other domains that are out of reach today, working in concert with AI and high-performance computing.
“By bringing our teams and technologies together, PsiQuantum and AMD will advance the future of computing, from the infrastructure that supports utility-scale quantum systems to new approaches for networking with silicon photonics and scaling the foundations of next-gen AI,” said Peng.
“Our work with PsiQuantum brings the breadth of AMD compute and software to this next frontier, combining our strengths to accelerate the path to utility-scale quantum computing,” said Mark Papermaster, EVP and CTO of AMD.
The collaboration aligns with the US Department of Energy’s recently released Quantum Genesis Priority Applications, which identify a key set of scientific problems that fault-tolerant quantum computers will be expected to solve.
The two companies’ planned initial focus on drug discovery falls within biological modeling, an identified emerging application area for Quantum Genesis.
They said that by leveraging PsiQuantum’s expertise in workflow and fault-tolerant algorithm development, these methodologies help elevate today’s GPU-based approaches beyond state-of-the-art while preparing critical industries for the arrival of fault-tolerant quantum computing.
Working with AMD, PsiQuantum researchers have optimized a highly accurate machine-learning decoder — called PRISM — for low-latency implementation on programmable hardware accelerators.
The result combines speed and accuracy in a design for real-time error correction in utility-scale photonic quantum computers.
Further, the combination of PsiQuantum’s workflows with AMD’s GPU expertise running large scale simulation has already delivered initial breakthrough results in simulation of covalent inhibitors, a class of molecules relevant in drug discovery for oncology.
PsiQuantum plans to build on these results and explore integrated accelerated computing solutions for commercial applications, initially focusing on the broader pharmaceutical research and drug discovery space.
Both companies will also explore expanding their collaboration with a footprint at the Illinois Quantum and Microelectronics Park (IQMP) in Chicago, the United States’ largest quantum computing project, where PsiQuantum serves as the anchor tenant.



